2023 Nurse's Drug Handbook Jones &. Bartlett Learning

2023 Nurse's Drug Handbook

Author: Jones &. Bartlett Learning
Add Your Review
$57.99 5799
8 items In Stock
  • Successful pre-order.Thanks for contacting us!
  • Order within
Wishlist Compare
Book Title
2023 Nurse's Drug Handbook
Author
Jones &. Bartlett Learning
ISBN
9781284274103
2023 Nurse's Drug Handbook is the most up-to-date, practical, and easy-to-use nursing drug reference. Updated annually, it provides accurate and timely facts on hundreds of drugs from A-Z. Written in a straightforward style with approachable terminology, it offers concise and consistently formatted drug entries organized alphabetically. The 2023 Nurse's Drug Handbook includes: - Index of all generic, trade, and alternate drug names - Chemical and therapeutic classes, FDA pregnancy risk category, and controlled substance schedule - Indications and dosages, as well as route, onset, peak, and duration information - Incompatibilities and contraindications - Interactions with drugs, food, and activities - Adverse reactions - Nursing considerations, including key teaching points for patients - Mechanism-of-action illustrations New drugs added to the 2023 Nurse's Drug Handbook include: Aducanumab-avwa, Atogepant, Baricitini, Cabotegravi, Dasiglucagon, Difelikefalin, Evinacumab-dgnb, Finerenone, Ibrexafungerp, Inclisiran, Molnupiravir, Nirmatrelvir, Ponesimod, Tezepelumab-ekko, Tralokinumab-ldrm, Vericiguat - Warnings and precautions - Updated appendices, including Uncommon Drugs - Bolded life-threatening Adverse Drug Reactions (ADRs)Binding Type: PaperbackAuthor: Jones &. Bartlett LearningPublisher: Jones & Bartlett PublishersPublished: 11/29/2022ISBN: 9781284274103Pages: 1630
2023 Nurse's Drug Handbook is the most up-to-date, practical, and easy-to-use nursing drug reference. Updated annually, it provides accurate and timely facts on hundreds of drugs from A-Z. Written in a straightforward style with approachable terminology, it offers concise and consistently formatted drug entries organized alphabetically. The 2023 Nurse's Drug Handbook includes: - Index of all generic, trade, and alternate drug names - Chemical and therapeutic classes, FDA pregnancy risk category, and controlled substance schedule - Indications and dosages, as well as route, onset, peak, and duration information - Incompatibilities and contraindications - Interactions with drugs, food, and activities - Adverse reactions - Nursing considerations, including key teaching points for patients - Mechanism-of-action illustrations New drugs added to the 2023 Nurse's Drug Handbook include: Aducanumab-avwa, Atogepant, Baricitini, Cabotegravi, Dasiglucagon, Difelikefalin, Evinacumab-dgnb, Finerenone, Ibrexafungerp, Inclisiran, Molnupiravir, Nirmatrelvir, Ponesimod, Tezepelumab-ekko, Tralokinumab-ldrm, Vericiguat - Warnings and precautions - Updated appendices, including Uncommon Drugs - Bolded life-threatening Adverse Drug Reactions (ADRs)

Binding Type: Paperback
Author: Jones &. Bartlett Learning
Publisher: Jones & Bartlett Publishers
Published: 11/29/2022
ISBN: 9781284274103
Pages: 1630
2023 Nurse's Drug Handbook is the most up-to-date, practical, and easy-to-use nursing drug reference. Updated annually, it provides accurate and timely facts on hundreds of drugs from A-Z. Written in a straightforward style with approachable terminology, it offers concise and consistently formatted drug entries organized alphabetically. The 2023 Nurse's Drug Handbook includes: - Index of all generic, trade, and alternate drug names - Chemical and therapeutic classes, FDA pregnancy risk category, and controlled substance schedule - Indications and dosages, as well as route, onset, peak, and duration information - Incompatibilities and contraindications - Interactions with drugs, food, and activities - Adverse reactions - Nursing considerations, including key teaching points for patients - Mechanism-of-action illustrations New drugs added to the 2023 Nurse's Drug Handbook include: Aducanumab-avwa, Atogepant, Baricitini, Cabotegravi, Dasiglucagon, Difelikefalin, Evinacumab-dgnb, Finerenone, Ibrexafungerp, Inclisiran, Molnupiravir, Nirmatrelvir, Ponesimod, Tezepelumab-ekko, Tralokinumab-ldrm, Vericiguat - Warnings and precautions - Updated appendices, including Uncommon Drugs - Bolded life-threatening Adverse Drug Reactions (ADRs)

Binding Type: Paperback
Author: Jones &. Bartlett Learning
Publisher: Jones & Bartlett Publishers
Published: 11/29/2022
ISBN: 9781284274103
Pages: 1630